Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Meet Natasha working on Flaskworks Eden biosimilarity. Article from 2023
https://advancedtherapiesapprenticeships.co.uk/latest-news/testimonial/meet-natasha/
Ahhhh ... yet more profound bullshit.
There will be no need for any biosimilarity trial. People claiming so either have no idea about where the winds are blowing at the FDA, or they have but have an incentive bullshitting about it.
Let's not bullshit any further. We all know.
Lets take a peek at biosimilarity, especially the go to guy in all matters of biosimilarity, Dr. Niazi
$NWBO
— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) February 6, 2024
Lets look into FDAs stance on biosimilars. And remember this guys name Sarfaraz Niazi Ph.D., SI, FRSB, FPAMS, FAACC. He is a regular one man army regarding FDAs stance on biosimilarity.
Lets see what he wrote about MHRAs stance first.https://t.co/VepkDZuGUN
No its not.
That is paid bashers telling people its a tell, while everyone knows, no one has no clue as to when MHRA approval hits.
Just a drop of piss wrong info in an ocean of piss wrong info.
But let me commend you on your - and colleagues - never ending quest to add to it.
Congratulations for not mentioning the lawsuit against 7 market makers, with Attorney of the Year Laura Posner handling the case for NWBO.
https://www.cohenmilstein.com/profile-attorney-of-the-year-winner-laura-posner-of-cohen-milstein-sellers-toll/
https://www.lawdragon.com/lawyer-limelights/2023-06-07-laura-posner-is-leading-the-way-in-investor-protection
You have a person who has 10 years anniversary bullshitting on this board, who still believe Duffy is a fictional character and obviously Regeneron is participating in said conspiracy.
Then you have people using the word pump about a stock, who have never enjoyed the privilege of share price rising when milestones hits and who are deaf dumb and blind when it comes to a decade of short and distort scamming and 7 markets makers evidently spoofing the share price.
Instead they revel in rhetorical bullshit ad nauseam and ad libitum.
But yes .... please do ring the bell and give a shout out about pump.
I'm sure that take is still wildly popular among "the earners".
As Linda Liau said in the censored webinar with Al Musella.
Off label.
$NWBO
— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) May 1, 2024
You're right!
"I’m firmly in the camp that says Northwest Bio will need to first receive approval for DCVax-L as a mono therapy added to the current standard of care"
Which Linda Liau stated in Q&A webinar.
POLY-ICLC OFF LABEL AFTER DCVAX-L APPROVAL.
WHY would she? 🤔 pic.twitter.com/F4Z6grIBd3
Why should we read it again, when clearly you haven't got an idea of how to interpret the written word?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174942999
While they continue to spoof? I wouldn't bet on that.
One thing is for certain, the evidence collection did not stop with the lawsuit and any indication of spoofing while negotiating, will not be taken lightly by LP, especially not put her in settlement mode.
But ... we'll find out eventually.
Whats a cure worth for grade III gliomas?
https://open.substack.com/pub/bamboolounge/p/whats-a-cure-for-grade-iii-gliomas?r=7rpu9&utm_campaign=post&utm_medium=email
Anyone should take time to read this paper, which brilliantly sums up the scam actors and their acting in the short and distort cabal hierarchy, not only in the NWBO case, but in general. Of course also mentioning the dysfunctional horde of paid shills working their nastiest undercover, enjoying the protection their pseudonyms MAY give them ... for the time being.
I expect we will soon see said actors chime in with contributions on said article countering it with yet more from the FUD department, only proving its veracity.
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4944293
Monty Python the Guards scene ... the equivalent of trying to reason with paid bashers.
Mr. Green is too difficult an incentive to counter, without upping the buy in.
Flipper: In response to your answer to LC. Not to your post per se.
One can't argue with people who are paid to promote only ignorant viewpoints.
And this is for Robotdroid.
I took the answer you received from ChatGPT and asked it to reflect over it in the light of the information I gave in this post over a year ago.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171886437
I really like these "usual fudspects" holidays, where it seems almost the whole establishment of fudders seems to have vacation at the same time and thus, their musings, their whinings .... just seem to have faded away instantly.
Can anyone tell me what this phenomenon is called?
Does it only take 6 pennies to rock their collective foundation of irrationalities and fud behaviour?
No no ... don't tell ....
I have reported this and more. 👍🏻
I said it when I read it.
The bears new narrative will be "ppDC is not DCVax"
Robert Prins has worked with DCVax-L as the dc vaccine used in all his immunotherapy resistance research during the last decade.
Linda Liau is involved. Poly-iclc is involved. Robert Prins and his team ran a 14 year long trial with dcvax-l and poly-iclc.
Exwannabe lied about that also and tried pathetically to refute that ATL-DC in that trial was not DCVax-L even to a degree that he commented on the official thread with that "observation" and became a laughing stock.
Now we begin again. New fud narrative for the next 4 years.
ppDC is not DCVax.
Yes it is.
NWBO, we need your help looking into this, immediately
$NWBO
— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) August 2, 2024
SEC has limited / recommended Custodian Banks and other US banks and thus danish Nordnet to sell and buy NWBO shares for retailers.
We are thus currently as retailers FUCKED, since Nordnet don't know much more. They are even talking about giving retailers a solution ...
Hey the guy who stickied Adam Feuersteins lie about conversations with UCLA and nonsense about ATL-DC, wants to chime in 🥳
Nemesis is short in anything. Also in his perspective of when he is packing his stuff and disappearing from this site, so his immense contribution in the bullshit arena, will be brief.
Last I looked Kings Hospital was a part of NHS.
Last I looked, the british politicians in the APPGBT group last year had these three recommendations for MHRA and NICE
The only thing that is certain right now is, that NO ONE on this or other stock boards, longs or shorts, know jack shit about when approval hits, no matter how hard one tries to convey that .....
The only two things that are for certain are, that approval decision COULD happen tomorrow AND WILL happen tomorrow OR later.
Silent management cares a peep, thats why they don't say a peep, knowing very well the history of fraudulent lawsuits whenever there's a possibility to twist and distort information to instigate them.
But by all means spout nonsense about blaming management, without even mentioning the obvious. That its plain for everone who is up to speed with the bare essentials, that market makers, hedges and shorters have been attacking the company financially since at least 2015, not least by use of spoofing.
If LP gets rich, its because the share price eventually rises. That would mean the NWBO shares which Advent Bioservices have also received as payment for services rendered in the past ALSO rises, that would mean retailers share price ALSO rises, that would mean self enrichenment in the end is enrichenment of everyone owning NWBO shares.
Its not rocket science, even though many would like us to believe in fairy tales of all sorts.
THESE fairy tales ... THATS where the real self enrichening takes place.
Thanks for having the IT guy chiming in. The dude notoriously known for having a paid bias, because how do one opt to be the laughing stock on the "ATL-DC issue" seriously arguing against all logic, that ATL-DC used in these two combo trials are not DCVax-L, when that has been stated by countless sources, including UCLA personel, articles and Linda Liau herself in a webinar?
https://clinicaltrials.gov/ct2/show/NCT01204684
https://clinicaltrials.gov/study/NCT04201873
Your continous streak of lying is impressive, but even a fudder like you, will have to stand down and count the accumulated pile of judas earned coins and move on to the next short and distort scam.
The MHRA in the UK endorsed historical controls, in the Pathway to a Cure report announced february 2023, in which british politicians from the All-Party Parliamentary Group on Brain Tumours, SPECIFICALLY pointed to DCVax-L and urged for MHRA to approve and NICE to endorse.
Refuting bullshit.
And of course the usual linking to bullshit refuting posts, in case there are anyone left on this board who gives a s*** about facts or just succumbs to the infinite nonsense spouted around here.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173223471
Due diligence on Ihub these days seems to be a western by John Ford
😂
Hold the banner of bullshit high ex. You are the IT employee of the month. 👍🏻
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514134/
https://www.nature.com/articles/s41392-024-01856-7
Just give ex two minutes to come up with some bullshit to refute it on behalf of his employers.
In fact let me try to ask ChatGbt to come up with nonsense.
Still occasionally dropping by to bullshit, huh? Yeah you lot really working overtime this weekend spouting your oldies but goodies nonsense.
From Smith on Stocks article
First icnolights awesome math skills.
I can understand you end with "no need to reply", because who on earth would want to see their baseless ignorant nonsense, called out for what it is right?
Once more. Its not a secret Linda Liau stated at webinar with Al Musella
When DCVax-L is approved poly-iclc can be used off-label.
I believe that over a paid shill IT employee any day, who also was wrong on ATL-DC for two years and never admitted that.
$NWBO
— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) May 9, 2024
Remember the Al Musella and Linda Liau webinar that was taken down.
The Q&A was removed due to threats:
"When approved poly-iclc can be added off label".
🍻 https://t.co/r5btS0VJwm
$NWBO
— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) March 3, 2024
Lets check some slides from Robert Prins' new video.
First this acknowledgements trial.
Look at the grant number for UCLA Spore (brain cancer, SPORE 1 project being DCVax-L and Keytruda)
1P50 CA211015 pic.twitter.com/V0x4Zy8KpJ
Your STATEMENT is on target. I don't think any longs here are against questions around this matter.
Let's sum up, what the reactions have been regarding the DCVax-L P3 trial results.
https://www.youtube.com/watch?v=cU_-1ECBMAU
LifeSpan at Rhode Island called in for press conference and this was the introduction.
NWBO had these milestones since October 2020 where share price was at $2.51. At that time we had 400 million LESS shares than today.
October 2020: NWBO announced the data lock for their Phase III trial of DCVax-L for Glioblastoma
December 2021: UK Manufacturing License
March 2022: Positive Top-Line Results
August 2022: Regulatory Approval for Pediatric Plan
December 2023: Submission of MAA
February 2024: Moving towards the production of GMP-compliant units?
March 2024: Board Appointment
May 2024: Nature article about results of DCvax-L in combo with poly-iclc: Enhanced Immune Response, Improved Survival, Safety and Biomarker Identification
June 2024: Exclusive In-License of Dendritic Cell Technology
August 2024: Primary completion date for SPORE 1 combo trial at UCLA with DCvax-L and Keytruda
The share price has dropped by 83.67% from October 2020 to today. In the same period, the number of shares outstanding has increased by 50%. This indicates that while dilution has played a significant role, the share price drop is much larger than the dilution alone would suggest.
Let's calculate
Decline Scenario (Average Price $0.75):
Shares Issued: 400 million
Average Share Price: $0.75
Total Money Raised: $300 million
Rise Scenario (Average Price $3.75):
Average Share Price: $3.75
Total Money Needed to Raise: $300 million (same as in the decline scenario)
Equivalent Shares Needed: 80 million
Summary
In the Decline Scenario: NWBO issued 400 million shares at an average price of $0.75 to raise $300 million.
If the Share Price Rose from $2.51 to $5: NWBO would have only needed to issue 80 million shares at an average price of $3.75 to raise the same $300 million.
320 MILLION SHARES DILUTED EXTRA DUE TO SPOOFING!
Now who to blame for those additional 320 million shares of dilution?
Management or the market makers having spoofed the share price, because come on ... you are not that stupid that you really DO BELIEVE, that the share price of $0.41 is indicative of a free and healthy functioning financial market?
320 million shares. Wow ... that makes for a hefty su,. when damages are going to be calculated when the lawsuit goes to discovery mode.
But back to your initial calculation of what NWBO's share price should be on approval.
There's the spoofed price and the fair price.
And of course a dismissal of MTD would be changing the landscape completely regarding continuing spoofing and whether NWBO can injunction market makers trade with NWBO.
So let's just initially see, how that goes.
But we can conclude, that your $1 number of dismissal of lawsuit is at best laughable, since its premise relies on having completely forget/chosen to forget, the effect of spoofing.
And I can assure you, NWBO and LP are never going to do deals, that don't adhere to a fair measured value, where the spoofing effect has been removed from the equation.
Being a fudder yourself, I can understand where your bias comes from, not least the kind of financial incentives it is founded upon.